CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz
Media Pack
News

Current Edition

Volume 18 Issue 3

Current Edition

Volume 18 Issue 3

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

iiCON Supports New Phase II Trial of Novel Pneumococcal Vaccine

The Infection Innovation Consortium: iiCON is managing a new £3.2 million Medical Research Council funded trial to enable progress into development of a new vaccine ...
27 November 2024 News development | drug
Continue Reading →
News

Glox Therapeutics Awarded Grant to Accelerate Development of Precision Antibiotics

Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, has announced it has secured £1 ...
27 November 2024 News antibiotics | development
Continue Reading →
News

Novartis and Ratio Enter Radiotherapeutics Partnership Worth $745m

Novartis and Ratio Therapeutics have entered into a worldwide licence and collaboration agreement worth $745m to advance a somatostatin receptor 2 (SSTR2)-targeting ...
27 November 2024 News biotechnology | drug
Continue Reading →
News

AstraZeneca Announces $3.5bn US Investment to Boost Research and Manufacturing

AstraZeneca (AZ) has announced a $3.5bn investment in the US aimed at expanding its research and manufacturing footprint by 2026. The funds will go towards a ...
27 November 2024 News AztraZeneca | development
Continue Reading →
News

Nipro Announces Major Expansion with New Medical Device Manufacturing Facility in Greenville, North Carolina, USA

July 17, 2024  GREENVILLE, N.C. — Nipro Medical Corporation, a leader in the global healthcare and medical device industry, proudly announces its significant...
18 July 2024 News development | drug
Continue Reading →
Volume 16 Issue 2

Integrating Medical Devices into Pharmacovigilance Portfolios   

How to Navigate the Latest EU Medical Device Regulatory Landscape to Successfully Adapt your Pharma Portfolio Understanding medical device regulations is essentia...
8 July 2024 Volume 16 Issue 2 | Editorial Archive development | drug
Continue Reading →
Volume 16 Issue 2

The End of Drug Shortages Begins with Data Transparency   

Connecting Quality, Regulatory, and Manufacturing Data is Key to Improving Supply Chain Agility For more than 15 years, shortages of critical and non-critical dru...
8 July 2024 Volume 16 Issue 2 | Editorial Archive development | drug
Continue Reading →
Volume 16 Issue 2

Has AI Transformed Pharma’s Supply Chain? Pharmaceutical Packaging Expert Weighs In  

The pharmaceutical industry is consistently seeking to improve, and now, with the rise of advanced artificial intelligence (AI), the industry has pursued leveraging ...
8 July 2024 Volume 16 Issue 2 | Editorial Archive blockchain | drug
Continue Reading →
Volume 16 Issue 2

Accelerating the Go-To-Market of Nasal Combination Products with Integrated Solutions   

Ear, Nose, Throat Market Trends Outlook  The overall Ear, Nose, and Throat (ENT) market was heavily impacted by Covid-19 pandemic due to masks-wearing, lockd...
8 July 2024 Volume 16 Issue 2 | Editorial Archive Artificial Intelligence | development
Continue Reading →
Volume 16 Issue 1

Harnessing The Power of Solid Form and Particle Engineering to Overcome Solubility and Bioavailability Challenges

An Interview with Veranova’s Craig Grant Persistent challenges in poor solubility and low bioavailability have long impeded the pharmaceutical development pipelin...
15 April 2024 Volume 16 Issue 1 | Editorial Archive Bioavailability | companies
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026